A therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes

PK201000776A0Undetermined Publication Date: 2010-09-27CHIESI FARMACEUTICI SPA
0 Cites 0 Cited by

Patent Information

Application Number
PK201000776
Authority / Receiving Office
PK · PK
Patent Type
Applications
Current Assignee / Owner
Filing Date
2010-09-06
Publication Date
2010-09-27
Patent Text Reader

Abstract

The present invention is directed to an exogenous pulmonary surfactant in combination with CuZn superoxide dismutase at a unit dose from 2000 to 10000 U / kg and catalase at a unit dose from 2000 to 4000 U / kg for the prevention of bronchopulmonary dysplasia (BPD).
Need to check novelty before this filing date? Find Prior Art